IFNA2 and COVID-19: To further characterize cell type intrinsic differences associated with COVID-19 and the presence of anti–IFN-α2 antibodies, we compared mRNA and surface protein abundances between COVID-19+ cases, COVID-19− cases, and healthy controls for each cell type.